Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03298802 · ClinicalTrials.gov registry record · Phase 3
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
A Phase 3 study, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- Phase 3
- Development phase
- 453
- Enrollment target
NCT03298802 is a Phase 3 study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 453 participants.
The verdict
NCT03298802, a Phase 3 study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 453 participants
- Enrollment target
Study Summary
Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension.
Interventions
- DRUG Placebo Tablet
- DRUG Hydrochlorothiazide 50mg Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 453 participants |
| Start Date | 2017-11-21 |
| Est. Completion | 2025-04-22 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03298802
The ClinicalTrials.gov registry entry for NCT03298802 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 453 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Tablet is the first listed.
NCT03298802 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03298802 about?
NCT03298802 is a clinical study titled "Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide". Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension.
What is the current status of trial NCT03298802?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 453 participants. The study started on 2017-11-21. Estimated completion is 2025-04-22.
What interventions are being tested in trial NCT03298802?
The interventions under investigation include: Placebo Tablet (DRUG), Hydrochlorothiazide 50mg Tablet (DRUG).
Who is sponsoring clinical trial NCT03298802?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.